Champions Oncology (CSBR) Other Operating Expenses (2010 - 2026)
Champions Oncology (CSBR) posted quarterly Other Operating Expenses of -$1000.0 for Q2 2026, up 99.66% year-over-year from -$500.85 in Q2 2025, and up 98.88% quarter-over-quarter from -$89000.0 in Q1 2026.
Champions Oncology (CSBR) Other Operating Expenses (2010 - 2026) Analysis & Trends
Champions Oncology's Other Operating Expenses history runs 17 years deep, the most recent figure standing at -$1000.0 for Q2 2026.
- In Q2 2026, Other Operating Expenses rose 99.66% year-over-year to -$1000.0; the TTM figure through Apr 2026 stood at -$110000.0 (up 62.46% YoY), while the FY2026 annual figure was -$111000.0, up 62.12% from the prior year.
- Other Operating Expenses for Q2 2026 stood at -$1000.0, up from -$89000.0 in the prior quarter.
- The five-year high for Other Operating Expenses was $10.0 million in Q2 2023, with the low at -$293000.0 in Q2 2025.
- The 5-year median for Other Operating Expenses is $8.6 million (2022), against an average of $6.4 million.
- The sharpest annual moves came in 2025 and 2026: Other Operating Expenses sank 103.1% in 2025, then surged 99.66% in 2026.
- Champions Oncology's Other Operating Expenses stood at $9.1 million in 2022, then dropped by 7.98% to $8.4 million in 2023, then rose by 12.46% to $9.5 million in 2024, then plunged by 100.21% to -$20000.0 in 2025, then jumped by 95.0% to -$1000.0 in 2026.
- Business Quant data shows CSBR's Other Operating Expenses at -$1000.0 in Q2 2026, -$89000.0 in Q1 2026, and -$20000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Champions Oncology | 71.17 Mn | 71.17 Mn | 7.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -1,000.00 |
| Jan 31, 2026 | -89,000.00 |
| Jul 31, 2025 | -20,000.00 |
| Apr 30, 2025 | -293,000.00 |
| Apr 30, 2024 | 9.46 Mn |
| Jan 31, 2024 | 9.65 Mn |
| Oct 31, 2023 | 8.41 Mn |
| Jul 31, 2023 | 9.38 Mn |
| Apr 30, 2023 | 9.99 Mn |
| Jan 31, 2023 | 9.46 Mn |
| Oct 31, 2022 | 9.14 Mn |
| Jul 31, 2022 | 8.74 Mn |
| Apr 30, 2022 | 7.84 Mn |
| Jan 31, 2022 | 7.96 Mn |
| Oct 31, 2021 | 7.25 Mn |
| Jul 31, 2021 | 6.97 Mn |
| Apr 30, 2021 | 7.32 Mn |
| Jan 31, 2021 | 6.12 Mn |
| Oct 31, 2020 | 6.99 Mn |
| Jul 31, 2020 | 6.54 Mn |